Division of Drug Metabolism and Molecular Toxicology, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aramaki-Aoba, Aoba-ku, Sendai, 980-8578, Japan.
Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.
Arch Toxicol. 2017 Jun;91(6):2365-2374. doi: 10.1007/s00204-016-1888-3. Epub 2016 Nov 10.
Perfluorocarboxylic acids (PFCAs) including perfluorooctanoic acid (PFOA) are environmental pollutants showing high accumulation, thermochemical stability and hepatocarcinogenicity. Peroxisome proliferator-activated receptor α is suggested to mediate their toxicities, but the precise mechanism remains unclear. Previous reports also imply a possible role of constitutive androstane receptor (CAR), a key transcription factor for the xenobiotic-induced expression of various genes involved in drug metabolism and disposition as well as hepatocarcinogenesis. Therefore, we have investigated whether PFCAs activate CAR. In wild-type but not Car-null mice, mRNA levels of Cyp2b10, a CAR target gene, were increased by PFOA treatment. PFCA treatment induced the nuclear translocation of CAR in mouse livers. Since CAR activators are divided into two types, ligand-type activators and phenobarbital-like indirect activators, we investigated whether PFCAs are CAR ligands or not using the cell-based reporter gene assay that can detect CAR ligands but not indirect activators. As results, neither PFCAs nor phenobarbital increased reporter activities. Interestingly, in mouse hepatocytes, pretreatment with the protein phosphatase inhibitor okadaic acid prevented an increase in Cyp2b10 mRNA levels induced by phenobarbital as reported, but not that by PFOA. Finally, in human hepatocyte-like HepaRG cells, PFOA treatment increased mRNA levels of CYP2B6, a CAR target gene, as did phenobarbital. Taken together, our present results suggest that PFCAs including PFOA are indirect activators of mouse and human CAR and that the mechanism might be different from that for phenobarbital. The results imply a role of CAR in the hepatotoxicity of PFCAs.
全氟羧酸(PFCAs)包括全氟辛酸(PFOA)是具有高蓄积性、热化学稳定性和肝癌致癌性的环境污染物。过氧化物酶体增殖物激活受体α(PPARα)被认为介导其毒性,但确切的机制尚不清楚。先前的报告也暗示了组成型雄烷受体(CAR)的可能作用,CAR 是一种关键的转录因子,可诱导各种与药物代谢和处置以及肝癌发生相关的基因的外源物诱导表达。因此,我们研究了 PFCAs 是否激活 CAR。在野生型但不是 Car 缺失型小鼠中,PFOA 处理可增加 Cyp2b10(CAR 的靶基因)的 mRNA 水平。PFCA 处理诱导了小鼠肝脏中 CAR 的核易位。由于 CAR 激活剂分为两种类型,配体型激活剂和苯巴比妥样间接激活剂,我们使用细胞报告基因检测法研究了 PFCAs 是否为 CAR 配体,该方法可以检测 CAR 配体但不能检测间接激活剂。结果,PFCAs 或苯巴比妥均未增加报告基因活性。有趣的是,在小鼠肝细胞中,如先前报道的那样,用蛋白磷酸酶抑制剂冈田酸预处理可预防苯巴比妥诱导的 Cyp2b10 mRNA 水平增加,但不能预防 PFOA 诱导的增加。最后,在人肝样 HepaRG 细胞中,PFOA 处理可增加 CYP2B6(CAR 的靶基因)的 mRNA 水平,苯巴比妥也可增加。综上所述,我们的研究结果表明,包括 PFOA 在内的 PFCAs 是小鼠和人 CAR 的间接激活剂,其机制可能与苯巴比妥不同。这些结果表明 CAR 在 PFCAs 的肝毒性中起作用。